MOVE.SW Stock — Price, Charts & Analysis

Medacta Group SA (MOVE.SW) has a trailing P/E of 28.64x and a forward P/E of 23.05x. This places MOVE.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

MOVE.SW trades with 28.64x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether MOVE.SW looks overvalued or undervalued.

MOVE.SW's P/E of 28.64x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

MOVE.SW's trailing EPS is CHF 4.49 and forward EPS is CHF 5.58. Reported earnings growth is 1.20%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Medacta Group SA generated for each share. MOVE.SW's trailing EPS is CHF 4.49, and investors usually prefer EPS that is positive and growing over time.

Medacta Group SA has a market cap of CHF 2.56B, making MOVE.SW a mid-cap stock based on the current market value shown on Worldtickers.

MOVE.SW's latest stock price on Worldtickers is CHF 128.60. The latest move is -CHF 1.40 or -1.08%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

MOVE.SW's quote includes a latest price of CHF 128.60. The market open is CHF 131.00. Previous close is CHF 130.00. The intraday range is CHF 128.60 to CHF 131.20.

MOVE.SW is down in the latest quote, with a move of -CHF 1.40 or -1.08%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

MOVE.SW generated CHF 683.83M in trailing revenue. Revenue growth is 12.50%, which helps show whether demand is expanding or slowing.

MOVE.SW's revenue growth is 12.50%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, MOVE.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 95.46M.

Gross margin is 67.07%. Margins show how efficiently Medacta Group SA turns revenue into profit.

Medacta Group SA carries CHF 262.77M and holds CHF 33.21M in cash.

MOVE.SW holds CHF 33.21M on its balance sheet.

MOVE.SW's book value per share is CHF 21.36.

Yes, Medacta Group SA pays a dividend of CHF 1.10 per share annually. The dividend yield is 85.00%. The payout ratio is 15.48%.

MOVE.SW's dividend yield is 85.00%. Its payout ratio is 15.48%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for MOVE.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Medacta Group SA's investor relations materials.

Institutions hold 15.27% of MOVE.SW shares. Insiders hold 69.66% of shares. Ownership mix helps investors understand how much of Medacta Group SA is held by professional investors and company insiders.

MOVE.SW has 19.91M shares outstanding. Float shares are 6M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for MOVE.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for MOVE.SW is CHF 5.58. Earnings growth is 1.20%. Revenue growth is 12.50%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

MOVE.SW's trailing EPS is CHF 4.49. Forward EPS is CHF 5.58. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

MOVE.SW is in the Healthcare sector. Its earnings multiple is 28.64x. Its latest displayed growth metric is 12.50%. Compare these figures with sector peers before deciding whether Medacta Group SA is stronger or weaker than average.

MOVE.SW trades at CHF 128.60. The stock trades at 28.64x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Medacta Group SA's fundamentals.

MOVE.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.98, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

MOVE.SW should be compared with companies in Medical Devices. Its earnings multiple is 28.64x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Medacta Group SA (MOVE.SW) operates in Healthcare, specifically Medical Devices. Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

MOVE.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

MOVE.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Medacta Group SA's official website listed on Worldtickers is www.medacta.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Medacta Group SA employs about 2.04K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Medacta Group SA is headquartered in Castel San Pietro, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

MOVE.SW is in the Healthcare sector and the Medical Devices industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

MOVE.SW has traded between CHF 128.20 and CHF 177.20 over the past 52 weeks. At CHF 128.60, it is 27.43% below the high and 0.31% above the low. The 52-week range helps gauge long-term price momentum.

MOVE.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is CHF 134.48 and its 200-day moving average is CHF 147.19.

MOVE.SW's RSI is 43.30. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

MOVE.SW's latest RSI reading is 43.30, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for MOVE.SW is near CHF 128.20. Key resistance is near CHF 139.40. Breaks above resistance or below support can change the short-term technical setup.

MOVE.SW's nearest reported support level is CHF 128.20. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

MOVE.SW's nearest reported resistance level is CHF 139.40. A breakout above resistance can improve momentum, especially when volume confirms the move.

MOVE.SW trades about 22.51K shares daily on average. The latest displayed volume is 28.78K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

MOVE.SW's MACD is -0.05, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

MOVE.SW is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 43.30 (neutral). MACD is bearish. Nearest support is around CHF 128.20. Resistance is around CHF 139.40. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 132.24 (-1.69% from price). MA50 is CHF 134.48 (-3.33% from price). MA200 is CHF 147.19 (-11.68% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. MOVE.SW's MA20 is CHF 132.24. MA50 is CHF 134.48. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

MOVE.SW's pivot is near CHF 131.87. Support is near CHF 128.20. Resistance is near CHF 139.40. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next upper resistance zone is near CHF 135.45. These levels help define risk and possible follow-through zones after a breakout or breakdown.

MOVE.SW's Bollinger range is roughly CHF 127.99 to CHF 136.49. Band width is near 6.42%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

MOVE.SW's ATR-based typical daily range is about 2.65%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 28.78K shares. Average volume is about 22.51K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

MOVE.SW's all-time high shown on Worldtickers is CHF 177.20. Its all-time low is CHF 39.80. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

MOVE.SW has a beta of 0.98, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.